CA
NZ
UK
AU
IND
US
● Cibus shares fell as much as roughly 16% in after-hours trading following second-quarter 2026 results released August 13, 2026.
● Clean Energy Fuels reported second-quarter 2026Revenueof $106.4 million, up from $102.6 million a year earlier.
● Aemetis reported second-quarter 2026 results on August 6, 2026, showing improved margins and a narrower net loss.
1. IRAN/HORMUZ: Ceasefire Expires With No Deal as Iran Claims Full Control of the Strait; Trump Threatens to Bomb Oman if It "Gets in the Way"
Eton Pharmaceuticals, Inc. (NASDAQ: ETON) shares closed up 44% at $58.86 after analysts at H.C. Wainwright adjusted their price target upward to $70.00 from $65.00.
Innate Pharma (NASDAQ: IPHA) shares closed down 14% at $2.17 following the pricing of a €30 million private placement consisting of 17.65 million shares at €1.70 per share.
Capricor Therapeutics (NASDAQ: CAPR) shares closed up 58% at $6.65 following news that the FDA will evaluate supplemental deramiocel efficacy results for Duchenne muscular dystrophy.
BeyondSpring Inc. (NASDAQ: BYSI) shares closed down 16% at $0.84 even afterSubsidiarySEED Therapeutics secured FDA Orphan Drug Designation for ST-01156 to treat neuroblastoma.
Valneva SE (NASDAQ: VALN) shares closed up 26% at $7.13 after the EMA validated the marketing application for PF-07307405, a Lyme disease vaccine candidate partnered with Pfizer.
Daré Bioscience, Inc. (NASDAQ: DARE) shares closed down 32% at $0.93 after the company announced the pricing of a $6.0 million registered direct offering at $1.37 per share, including concurrent Series A and B warrants.
Please wait processing your request...